ARCHIVES

FDA Advisors Unanimously Turn Down GPC Biotech’s Orplatna for Prostate Cancer.

This article is from The Cancer Letter archive.

Vol. 33 No. 29 | July 27, 2007

Download PDF Visit The Full Archive

Related Articles

White House Yet To Name NCAB, Cancer Panel Members

February 11, 2011

NSABP Executive Committee Joins Fisher In Suit Against Pitt

August 5, 1994

Contracting Dispute and Software Bugs Plague NCI’s $200 Million Bioinformatics Venture

February 25, 2011

New RFAs on Retinoids & Carotenoids, Tobacco, NMR Research Resistance

July 27, 1984

Joseph Simone Accepts Chief Physician Job At Memorial Hospital, Succeeding DeVita

February 21, 1992

NCI Planning Phase III Study Of Avastin For Metastatic Colorectal Cancer

June 27, 2003